FOLH1 and neoplasm: Using an approach we have previously described, neoantigens were induced in tumor cells by inhibition of the nonsense-mediated mRNA decay (NMD) process using siRNAs to downregulate Smg-1, a key mediator of the NMD pathway that was targeted to the tumors in situ by conjugation to a PSMA-binding aptamer29.